Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.
Where this comes from
- Record sourced from PubMed, PMID 41557643.
- Also identified by DOI 10.1371/journal.pone.0341486 and PMC identifier 12818613.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0323167.].